Last Updated: May 10, 2026

Profile for Ukraine Patent: 106231


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 106231

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,734,847 Apr 23, 2030 Genus TIVORBEX indomethacin
8,992,982 Apr 23, 2030 Genus TIVORBEX indomethacin
9,089,471 Apr 23, 2030 Genus TIVORBEX indomethacin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Ukraine Patent UA106231

Last updated: July 30, 2025


Introduction

Ukraine Patent UA106231 pertains to a pharmaceutical invention registered within Ukraine’s patent system, reflecting the innovation landscape in the Ukrainian pharmaceutical patent domain. Analyzing the scope and claims provides insight into the patent’s breadth, legal robustness, and position relative to other patents. Understanding its landscape implications informs strategic decisions for pharmaceutical companies, patent explorers, and R&D entities operating in Ukraine.


Patent Overview

UA106231 was granted to protect a specific pharmaceutical invention, with scope encompassing unique chemical entities, formulations, intermediates, or methods associated with drug development. While detailed official documentation is required for comprehensive analysis, patent documents typically delineate claims that define the legal boundaries of protection.


Scope of the Patent

The scope comprises the breadth of protection—what exactly the patent covers. In UA106231, the scope primarily depends on the language and breadth of its claims, which specify:

  • Chemical Composition: The patent likely claims a novel chemical compound or a class of compounds with specific structural features, such as substituted heterocycles, peptides, or small molecules.
  • Methods of Synthesis: It may include specific processes for manufacturing the drug, emphasizing novel synthetic routes that improve yield, purity, or cost.
  • Pharmaceutical Formulations: The patent could extend to particular formulations, including dosage forms, delivery systems, or co-administration regimens.
  • Therapeutic Applications: It may specify indications for treatment, e.g., anticancer, antiviral, or anti-inflammatory applications, provided they are inventive over prior art.

The scope’s scope is further clarified by the claims’ language, which in Ukrainian patents often aligns with international standards, emphasizing novelty, inventive step, and industrial applicability.


Claims Analysis

The claims define the scope of legal protection and are divided into independent and dependent claims:

1. Independent Claims

Typically broad, independent claims outline the core invention—such as a novel compound with a specific chemical structure, or a unique method of manufacturing. For example:

“A compound of formula I, wherein R1, R2, R3 are selected from the group consisting of...”

Such claims aim to cover the primary inventive concept broadly, providing a shield against infringing variants.

2. Dependent Claims

Dependent claims narrow the scope, adding specific details or particular embodiments. Examples include:

  • Specific substituents or stereochemistry.
  • Particular versions of the synthesis method.
  • Specific dosage ranges or formulations.

This layered claim structure enhances patent robustness by protecting both broad and specific embodiments.

3. Claim Language and Limitations

The clarity and precision of claim language are crucial. Overly broad claims may be invalidated under prior art, but overly narrow claims limit enforceability. Comparing UA106231’s claims to global patent standards, the motivational factors involve balancing scope with enforceability.


Patent Landscape in Ukraine

1. Related Patents and Patent Family

Patent landscapes look at related patents filed in Ukraine and internationally. Key elements to consider include:

  • Family Members: Whether UA106231 is part of a broader patent family covering various jurisdictions.
  • Prior Art: Analyzing similar patents and published literature to identify overlapping claims or inventive differences.
  • Competitor Filings: Identifying filings by competitors or research institutions indicates landscape saturation or opportunities.

2. Ukrainian Patent System Context

Ukraine's patent system is aligned with the European Patent Convention (EPC) standards, emphasizing novelty, inventive step, and utility. The legal environment fosters protection in local markets and offers pathways for patent enforcement.

3. Overlaps with International Patents

If UA106231 shares similarities with international patents (e.g., through PCT publications or filings in the EPO), it indicates a strategic positioning or potential for licensing negotiations.

4. Patent Duration and Maintenance

The patent's validity period, typically 20 years from filing in Ukraine, and maintenance fee compliance are essential for ongoing enforceability and commercial strategy.


Legal and Commercial Implications

  • Enforceability: The scope, combined with claim clarity, influences enforceability against infringing products.
  • Innovation Strength: The breadth of claims signals the patent’s strength; broad claims afford stronger protection but may face validity challenges.
  • Competitive Landscape: Patent positioning shows where competitors may have similar protection, influencing R&D or licensing strategies.
  • Market Entry: UA106231 can serve as a barrier to market entry, especially if it covers essential active pharmaceutical ingredients (APIs) or formulations.

Limitations and Challenges

  • Prior Art Risks: Overlapping with existing patents or literature can threaten validity.
  • Claim Narrowness: Overly narrow claims limit enforcement scope.
  • Patent Term Limitations: As patents age, their protective value diminishes, prompting innovation cycles.

Conclusion

UA106231 represents a strategic intellectual property asset within Ukraine’s pharmaceutical sector. Its scope, defined primarily by its claims, aims to balance broad coverage with enforceability. The patent landscape exhibits a competitive matrix influenced by international filings, local innovation, and prior art considerations.


Key Takeaways

  • Scope Optimization: Clear, balanced claim language maximizes protection while minimizing validity risks.
  • Landscape Awareness: Patent families and related international applications influence enforcement and licensing opportunities.
  • Strategic Position: The patent’s strength depends on its claims’ breadth and its alignment with the Ukrainian patent environment.
  • Continuity Planning: Maintenance and ongoing innovation efforts are essential to uphold patent value.
  • Legal Vigilance: Regular landscape analyses help anticipate challenges and opportunities.

FAQs

1. What types of claims are most common in Ukrainian pharmaceutical patents like UA106231?
Claims usually include chemical composition claims, process claims for synthesis, and formulation claims, reflecting the invention’s core aspects and applications.

2. How does Ukraine’s patent system impact the protection of pharmaceutical inventions?
Ukraine follows EPC standards, emphasizing novelty and inventive step, which ensures patent robustness but requires careful claim drafting to withstand validity challenges.

3. Can UA106231 be enforced against international competitors?
Protection is limited geographically; enforcement applies within Ukraine. For broader protection, patent owners often seek extensions through international filings or regional agreements.

4. How does patent landscape analysis assist in strategic drug development?
It identifies overlapping IP, potential infringements, and opportunities for licensing or freedom-to-operate assessments.

5. What are the future considerations for patent holders of UA106231?
Patent holders should monitor competing filings, maintain compliance, and consider patent term extensions or follow-up innovations to sustain competitive advantage.


References

[1] State Intellectual Property Service of Ukraine. Patent Database.
[2] European Patent Office. Guidelines for Examination of Patent Applications.
[3] World Intellectual Property Organization. Patent Landscape Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.